Articles on disposables: implementation, validation, cost-benefit analysis - BioPharm International


The advantages and disadvantages of disposables, along with cost-benefit analyses, validation strategies, and implementation approaches.


February 2, 2010

If you are looking for additional information (or terms not included in our glossary), here are some places to begin your search.

End-to-End Deployment of Single-Use Technology in Aseptic Filling of Vaccines at GSK

February 1, 2010

How this Big Pharma company successfully implemented disposable technologies in its manufacturing plant.

Disposables in Rapid Response Manufacturing: The Next Steps

December 1, 2009

Suppliers, manufacturers, and governments must work together to plan how best to develop and deploy disposable systems for emergency response.

Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L

December 1, 2009

A case study assesses freezing time and physical robustness under stress.

A Review of Sterile Connectors

November 2, 2009

Many factors must be considered when choosing a sterile connector for a given process.

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

November 2, 2009

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.

Integrating Single-Use Connection Components into Filter Integrity Testing Reduces Manufacturing Risk

November 2, 2009

Single-use connections can help drug manufacturers maximize efficiency in every step of the manufacturing process.

Freeze Bulk Bags: A Case Study in Disposables Implementation

November 2, 2009

Genentech's evaluation of single-use technologies for bulk freeze-thaw, storage, and transportation.

Single-Use Bioprocessing Equipment

September 18, 2009

To assess current trends in single-use bioprocessing equipment, BioPharm International turned to John Boehm, bioprocessing business unit manager, Colder Products Company; Mandar Dixit, head of product management?filtration technologies, Sartorius Stedim Biotech; Geoff Hodge, managing director of process technology Xcellerex, Inc.; Günter Jagschies, senior director of strategic customer relations, life sciences, biotechnologies, GE Healthcare; Mani Krishnan, director of product management, Mobius single-use technologies, Millipore Corporation; and Jerry Martin, senior vice president of scientific affairs, Pall Life Sciences, and board chairman and technology chair at BPSA.



Click here